253 related articles for article (PubMed ID: 9594257)
1. Immunofluorescence study of type IV collagen alpha chains in epidermal basement membrane: application in diagnosis of X-linked Alport syndrome.
Ding J; Yang J; Liu J; Yu L
Chin Med J (Engl); 1997 Aug; 110(8):584-6. PubMed ID: 9594257
[TBL] [Abstract][Full Text] [Related]
2. Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody.
Yoshioka K; Hino S; Takemura T; Maki S; Wieslander J; Takekoshi Y; Makino H; Kagawa M; Sado Y; Kashtan CE
Am J Pathol; 1994 May; 144(5):986-96. PubMed ID: 8178947
[TBL] [Abstract][Full Text] [Related]
3. Distribution of familial nephritis antigen in normal tissue and renal basement membranes of patients with homozygous and heterozygous Alport familial nephritis. Relationship of familial nephritis and Goodpasture antigens to novel collagen chains and type IV collagen.
Kleppel MM; Kashtan C; Santi PA; Wieslander J; Michael AF
Lab Invest; 1989 Sep; 61(3):278-89. PubMed ID: 2671490
[TBL] [Abstract][Full Text] [Related]
4. A clinicopathological study of Alport syndrome and detection of type IV collagen chains in Alport patients.
Chen N; Pan X; Ren H; Dong D
Chin Med J (Engl); 1998 Sep; 111(9):797-802. PubMed ID: 11155669
[TBL] [Abstract][Full Text] [Related]
5. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
6. Comparative distribution of the alpha 1(IV), alpha 5(IV), and alpha 6(IV) collagen chains in normal human adult and fetal tissues and in kidneys from X-linked Alport syndrome patients.
Peissel B; Geng L; Kalluri R; Kashtan C; Rennke HG; Gallo GR; Yoshioka K; Sun MJ; Hudson BG; Neilson EG
J Clin Invest; 1995 Oct; 96(4):1948-57. PubMed ID: 7560087
[TBL] [Abstract][Full Text] [Related]
7. Immunohistologic studies of type IV collagen in anterior lens capsules of patients with Alport syndrome.
Cheong HI; Kashtan CE; Kim Y; Kleppel MM; Michael AF
Lab Invest; 1994 Apr; 70(4):553-7. PubMed ID: 8176894
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of type IV collagen subchains in the glomerular basement membrane of patients with Alport syndrome with confocal microscopy.
Su J; Liu ZH; Zeng CH; Wei-Gong ; Chen HP; Li LS
Nephrol Dial Transplant; 2006 Jul; 21(7):1838-47. PubMed ID: 16574687
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study for the diagnosis of Alport's syndrome.
Wongtrakul P; Shayakul C; Parichatikanond P; Suthipinittharm P; Amjaroen C; Kaewkaukul N; Vongirad A; Ongajyooth L
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S171-81. PubMed ID: 17718259
[TBL] [Abstract][Full Text] [Related]
10. [Immunohistochemical study of type IV collagen chain distribution within basement membrane in patients with Alport syndrome].
Pan X; Chen N; Chen X
Zhonghua Nei Ke Za Zhi; 1997 Dec; 36(12):812-5. PubMed ID: 10451936
[TBL] [Abstract][Full Text] [Related]
11. A novel Cys1638Tyr NC1 domain substitution in alpha5(IV) collagen causes Alport syndrome with late onset renal failure without hearing loss or eye abnormalities.
Wilson JC; Yoon HS; Walker RJ; Eccles MR
Nephrol Dial Transplant; 2007 May; 22(5):1338-46. PubMed ID: 17277342
[TBL] [Abstract][Full Text] [Related]
12. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen.
Wang XP; Fogo AB; Colon S; Giannico G; Abul-Ezz SR; Miner JH; Borza DB
J Am Soc Nephrol; 2005 Dec; 16(12):3563-71. PubMed ID: 16236801
[TBL] [Abstract][Full Text] [Related]
13. Renal disease in carrier female dogs with X-linked hereditary nephritis. Implications for female patients with this disease.
Baumal R; Thorner P; Valli VE; McInnes R; Marrano P; Jacobs R; Binnington A; Bloedow AG
Am J Pathol; 1991 Oct; 139(4):751-64. PubMed ID: 1928300
[TBL] [Abstract][Full Text] [Related]
14. Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation.
Brainwood D; Kashtan C; Gubler MC; Turner AN
Kidney Int; 1998 Mar; 53(3):762-6. PubMed ID: 9507224
[TBL] [Abstract][Full Text] [Related]
15. Type VII collagen in Alport syndrome.
Giannakakis K; Massella L; Grassetti D; Dotta F; Perez M; Muda AO
Nephrol Dial Transplant; 2007 Dec; 22(12):3501-7. PubMed ID: 17670768
[TBL] [Abstract][Full Text] [Related]
16. [Alport's syndrome: apropos of 2 families].
Grünfeld JP
Nephrologie; 2000; 21(6):295-8. PubMed ID: 11117109
[TBL] [Abstract][Full Text] [Related]
17. Thin glomerular basement membrane disease: clinical significance of a morphological diagnosis--a collaborative study of the Italian Renal Immunopathology Group.
Frascà GM; Onetti-Muda A; Mari F; Longo I; Scala E; Pescucci C; Roccatello D; Alpa M; Coppo R; Li Volti G; Feriozzi S; Bergesio F; Schena FP; Renieri A;
Nephrol Dial Transplant; 2005 Mar; 20(3):545-51. PubMed ID: 15618242
[TBL] [Abstract][Full Text] [Related]
18. Epidermal basement membrane alpha 5(IV) expression in females with Alport syndrome and severity of renal disease.
Massella L; Onetti Muda A; Faraggiana T; Bette C; Renieri A; Rizzoni G
Kidney Int; 2003 Nov; 64(5):1787-91. PubMed ID: 14531812
[TBL] [Abstract][Full Text] [Related]
19. [Molecular genetics of Alport syndrome].
Yamazaki H; Saito A; Nakagawa Y; Arakawa M
Nihon Rinsho; 1992 Dec; 50(12):3021-6. PubMed ID: 1491454
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease.
Borza DB; Hudson BG
Springer Semin Immunopathol; 2003 May; 24(4):345-61. PubMed ID: 12778332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
